Healthcare -
Biotechnology - NASDAQ - US
$ 4.43
-1.56 %
$ 376 M
Market Cap
-3.75
P/E
TERN - OPERATING EXPENSES
Operating Expenses TERN - Terns Pharmaceuticals, Inc.
103 M
LAST VALUE
42.00%
2 YEAR CAGR
40.92%
5 YEAR CAGR
0.00%
10 YEAR CAGR